An anticancer strategic dilemma: to kill or to contain. The choice of the pharmaceutical industry in 2009.
about
Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.Therapeutic drug monitoring of imatinib in chronic myeloid leukemia: experience from 1216 patients at a centralized laboratory.
P2860
An anticancer strategic dilemma: to kill or to contain. The choice of the pharmaceutical industry in 2009.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An anticancer strategic dilemm ...... armaceutical industry in 2009.
@en
An anticancer strategic dilemm ...... armaceutical industry in 2009.
@nl
type
label
An anticancer strategic dilemm ...... armaceutical industry in 2009.
@en
An anticancer strategic dilemm ...... armaceutical industry in 2009.
@nl
prefLabel
An anticancer strategic dilemm ...... armaceutical industry in 2009.
@en
An anticancer strategic dilemm ...... armaceutical industry in 2009.
@nl
P2860
P1476
An anticancer strategic dilemm ...... harmaceutical industry in 2009
@en
P2093
Bernard Uzzan
P2860
P304
P356
10.1111/J.1472-8206.2010.00849.X
P577
2011-06-01T00:00:00Z